Eukaryotic selenocysteine tRNA has the 9/4 secondary structure  by Mizutani, Takaharu & Goto, Chiharu
Eukaryotic selenocysteine tRNA has the 9/4 secondary structure
Takaharu Mizutani*, Chiharu Goto
Faculty of Pharmaceutical Sciences, Nagoya City University, Mizuho-ku, Nagoya 467-8603, Japan
Received 14 December 1999
Edited by Julio Celis
Abstract There are two secondary structure models for the
eukaryotic selenocysteine (Sec) tRNASec. One model, the 9/4
structure, was experimentally tested and possesses acceptor and
T-stems with 9 and 4 bp, respectively [Sturchler et al., 1993;
Hubert et al., 1998]. The other one, the 7/5 secondary structure
with a bulge in the T-stem, was derived from theoretical
calculation [Ioudovitch and Steinberg, 1999]. In this report, we
show more experimental results supporting the 9/4 secondary
structure. Several tRNASec mutants, whose secondary structure
can adopt only the 9/4 structure, were active for serylation and
selenylation. Some mutants that cannot base-pair between
positions 26 and 44 to provide the 6 bp anticodon stem were
still active, inconsistent with the model by Steinberg. We also
show that the orientation of the V-arm directly or indirectly
influences the selenylation activity, and that the rigid 6 bp D-
stem is important. Finally, we conclude that all tRNAsSec possess
the 13 bp domain II made by the stacking of the colinear AA and
T-stems, whether they present the 9/4 structure in Eukarya and
Archaea or the 8/5 structure in bacteria.
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1. Introduction
Selenocysteine (Sec) plays a key role in the redox function
of glutathione peroxidases, thioredoxin reductases, and iodo-
thyronine deiodinases. Sec is formed on its tRNASec from
seryl-tRNASec by Sec synthase. The selenocysteine tRNASec
has two characteristic features. It possesses the anticodon
UCA complementary to the selenocysteine codon UGA. The
other feature is the peculiar 9/4 secondary structure, di¡ering
from the general standard 7/5 tRNA structure; 9 and 7 stand
for the lengths of the AA stem, 4 and 5 for those of the T-
stem. The 9/4 secondary structure of the eukaryotic tRNASec
was suggested based on the secondary structure of the Esche-
richia coli tRNASec having the 8/5 structure [1]. Experimental
evidence arguing in favor of the 9/4 secondary structure of the
eukaryotic tRNASec has been shown [2,3]. This secondary
structure was di¡erent from the 7/5 model which has an un-
expected bulge in the T-stem [4]. Recently, it has been shown
that the archaeal tRNASec can adopt the 9/4 secondary struc-
ture as well [3,5]. Thus, it is considered that tRNASec can fold
into the 9/4 or 8/5 secondary structures. However, Ioudovitch
and Steinberg [5] have maintained ¢rmly their 7/5-bulge sec-
ondary structure model for the eukaryotic tRNASec, based on
theoretical considerations [6^8]. They however agreed for the
existence of the 8/5 and 9/4 structures of eubacterial and arch-
aeal tRNAsSec, respectively [5]. Their theory can mislead the
readers that the eukaryotic tRNASec adopts the 7/5-bulge sec-
ondary structure only. The purpose of this report is to clarify
the situation by bringing new arguments in favor of the 9/4
secondary structure of the eukaryotic tRNASec.
The selenocysteine synthesis and its incorporation into se-
lenoproteins is well established in bacteria. The tRNASec is
¢rst charged with Ser by the conventional Ser-tRNA synthe-
tase (SerRS). The product Ser-tRNASec is subsequently bound
by selenocysteine synthase (SecS), an enzyme which converts
the Ser-residue to Sec, using an activated phosphoselenoate
compound as the Se-donor. Sec-tRNASec is then brought to
an in frame Sec-specifying UGA codon by a speci¢c elonga-
tion factor di¡erent from EF-Tu.
The current state of research on the eukaryotic tRNASec
can be summarized as follows. The functional sites on tRNAs
for the aminoacyl-tRNA synthetases have been termed the
identity sites on tRNA [9]. We determined the recognition
sites on for the selenocysteine synthase on the tRNASec
[10,11]. Eukaryotic tRNASec exhibits an aminoacyl acceptor-
stem with a unique length of 9 bp. None of the point muta-
tions on the 9 bp AA-stem signi¢cantly modi¢ed the seleny-
lation level. In contrast, reduction of the AA-stem length to 8
bp led the tRNASec to lose or reduce its ability to e⁄ciently
support selenylation [12]. This result provided strong evidence
that the length of the acceptor stem is of prime importance for
the serine to selenocysteine conversion step.
The tRNASec has a short 4 bp T-stem and an elongated 6 bp
D-stem, as well as the long 9 bp AA-stem described above.
We showed that the elongated 6 bp D-stem was another es-
sential element on this tRNA, because tRNASec mutants hav-
ing a D-stem length decreased to 4 bp were inactive in sele-
nylation. Therefore, the long 9 bp AA-stem and the elongated
6 bp D-stem are two essential recognition sites for selenyla-
tion. This was con¢rmed by an identity switch from tRNASer
to tRNASec. In this experiment, the 7 bp AA-stem and 4 bp
D-stem of tRNASer were converted to the active mutants hav-
ing the 9 bp AA-stem and 6 bp D-stem [13].
We succeeded in the conversion of tRNASer to tRNASec,
but the selenylation activity was weak and about 1/20 of that
of the native tRNASec [14]. This suggests an in£uence of base
speci¢city on the tRNASec and/or the involvement of the ori-
entation of the V-arm. We also showed that the 4 bp T-stem
of the tRNASec is not important for selenylation, because
tRNASec mutants having 3, 4 or 5 bp T-stems still possessed
selenylation activity [14]. The length of the coaxial helix (do-
main II) formed by the stacking of the AA and T-stems is
essential for serylation, because tRNASec having 12 or 13 bp
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of domain II were still active, but not the mutants carrying 11
or 14 bp of domain II. This suggests that the SerRS measures
the length between the discriminating base G73 and the V-arm
[14,15].
The secondary structure model for the tRNASec was pro-
posed based on enzymatic and chemical probing [2]. RNase
T2 did not digest the bulge position in the 7/5-bulge model
and modi¢cation with dimethyl sulfate showed the absence of
this bulge in the 7/5-bulge structure of Steinberg et al. Despite
this experimental evidence, Ioudovitch and Steinberg [8] con-
cluded that our data ¢t the 7/5-bulge model better than the 9/4
secondary structure model. Their analysis revealed the ability
to comply with their L-form compensatory rules within the 7/5
structure. After the publication by Ioudovitch and Steinberg
[8], Krol and coworkers presented more experimental data
supporting the eukaryotic 9/4 model, as well as a secondary
structure model for the tRNASec of the Archaea Methanococ-
cus jannaschii which can also fold into the 9/4 structure model
[3]. This secondary structure model for the archaeal tRNASec
has been also con¢rmed by Ioudovitch and Steinberg [5]. They
Fig. 1. Eukaryotic active selenocysteine tRNAs. A: Secondary structure models of various tRNAs. B: The TLC patterns of [75Se]Sec produced
on and liberated from those tRNAs.
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showed that the archaeal tRNASec adopts the 9/4 secondary
structure only, because they failed to construct the 7/5 second-
ary structure model they proposed for the eukaryotic counter-
part. From these circumstances, we show several active
tRNASec mutants that can fold only into the 9/4 secondary
structure. It was impossible to construct the 7/5 secondary
structure model with these mutants. They were active in solu-
tion, showing that they adopt the 9/4 secondary structure in
the reaction mixture to prepare the [75Se]Sec-tRNA. As a
matter of fact, these mutants were active for serylation by
the SerRS in the ¢rst step of the Sec-tRNA synthesis. As
well as the 9/4 structure, we showed other important results,
such as the rigid 6 bp D-stem and the orientation of the V-
arm. Active tRNASec mutants having only the 9/4 secondary
structure.
2. Materials and methods
2.1. tRNA constructs and in vitro transcription by T7 polymerase
Synthetic mammalian wild-type (wt) and mutant Sec tRNAs were
constructed by hybridizing six couples of 14^24mer oligonucleotides
or a couple of 90mer oligonucleotides containing the desired sequen-
ces as described in [12,13]. In these constructs, the promoter of the T7
RNA polymerase is included immediately 5P of the coding sequence.
Conditions for transcription in vitro with T7 RNA polymerase were
as described in [12,13]. The RNA products were puri¢ed by gel elec-
trophoresis and electroeluted.
2.2. Serylation and selenylation of tRNAs
Prior to use, tRNA transcripts were renatured by heating to 65‡C
for 3 min and then at 25‡C for 5 min. tRNA in 20 Wl of 0.2 M
HEPES^Na (pH 7.4), 20 mM MgCl2, 20 mM KCl, 10 mM mercap-
toethanol, 0.4 mM serine, 5 mM ATP, and 5 Wg SerRS were mixed
with 10 Wl of [75Se]HSe3 (2 Ci/mmol), 10 Wl of selenocysteine synthase
and 10 Wl of selenide-activating protein, and incubated at 30‡C for 2 h
[11]. After ethanol precipitation, alkaline hydrolysis of the [75Se]Sec-
tRNASec in 2 M NH4OH, 2 M mercaptoethanol for 30 min at 37‡C
released [75Se]Sec, which was separated by TLC on silicagel G plates
in n-butanol:acetic acid:water (4:1:1). 75Se radioactivity was mea-
sured with a Fuji Bioimage BAS 2500 analyzer. Cold Sec (a generous
gift of Prof. K. Soda, Kyoto University, Kyoto, Japan) was cochro-
matographed as a control and revealed by ninhydrin reaction.
3. Results and discussion
3.1. Active tRNASec mutants having only the 9/4 secondary
structure
Fig. 1A shows the secondary structures of several tRNASec
mutants and the tRNASer. Mutants X8,T13 and T21 derived
from the tRNASec, Y8I, Y11H and Y11L from tRNASer. All
tRNAs except the tRNASer in Fig. 1 were active for selenyla-
tion, as shown in Fig. 1B. T13 and T21 are mutants convert-
ing the U6*U67 (* indicates non-base-pairing) base pair in the
AA-stem of tRNASec to U6-A67 and C6-G67, respectively
(the numbering is according to the secondary structure model
by Sturchler et al. [2]). These two mutants conserved full
serylation and selenylation activities [12]. Other mutants hav-
ing A6-U67 or G6-C67 were also fully active in serylation and
selenylation. These tRNASec mutants adopt only the 9/4 sec-
ondary structure, like the archaeal tRNASec. The mutant hav-
ing G6-C67 is the same as the wt archaeal tRNASec, for which
Ioudovitch and Steinberg did not propose the 7/5 secondary
structure model and agreed with the 9/4 structure. X8 is an
active mutant of the tRNASec obtained by exchanging the
AA-stem with that of tRNASer [13]. This showed that SecS
did not require base-speci¢city in the AA-stem but only the
length of the 9 bp AA-stem. This conclusion is consistent with
the results by [12].
The other three mutants Y8I, Y11H and Y11L in Fig. 1 are
active derivatives of tRNASer by an identity switch. Y8I is an
active mutant with a 5 bp T-stem. This mutant having a 14 bp
of domain II was weak in serylation but high in selenylation,
like X33 in a previous paper [14]. Y11H and Y11L are active
mutants having the 4 bp T-stem obtained by a 1 bp deletion
from the original T-stem of tRNASer and the 9 bp AA-stem
obtained by addition of the 2 bp, U6*U67 and G7-C66. These
two mutants have the V-arm of tRNASer. In addition, C48,
converted from A48, could not base-pair with U67, because
original A48 base-paired with U67 in the 7/5-bulge model by
Ioudovitch and Steinberg. This indicates that these two active
mutants, Y11H and Y11L, can only adopt the 9/4 structure,
not the 7/5-bulge secondary structure.
3.2. The rigid 6 bp D-arm lifts up domain II
In a previous report, the 6 bp D-stem was shown essential
for selenylation activity [13]. However, not only the length of
the D-stem, but also the sequence, revealed important to ele-
vate the selenylation activity. Fig. 2 shows the relationship
between structure of the D-stem and activity. The tRNAs
having full activity are native Sec tRNA (U12-G23),
X35(C12-G23) and X17(U14-A21). These D-stems possess a
rigid structure. The activity of X29 having an A13*G22 mis-
match was slightly less than that of the tRNASec wt (about
60% of full activity) and that of X14 having the two A12*G23
and A13*G22 mismatches was 35%. The activity of X15 hav-
ing the G15-U20a base pair dropped to 10%. T12 having
G15*G20a and a 5 bp D-stem was inactive, showing that
Fig. 2. Relationships between the structure of the D-stem and the
selenylation activity.
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the 6 bp D-stem is essential. T16 with A14*A21 and U2 with
A14*C21 were inactive. Thus, the mutants having unpaired
portions, such as X15, T16, and U2 were very weak or inac-
tive. This shows that a rigid 6 bp D-stem is better for recog-
nition by SecS. Base pair U12-G23 in the 6 bp D-stem may
act in a base-speci¢c manner. The 6 bp D-stem is completely
di¡erent from the 3 bp D-stem in classical tRNAs. This rigid
6 bp D-stem lifts up domain II of tRNASec and the junction
between domains I and II should be in£uenced by this 6 bp
D-stem.
The model by Ioudovitch and Steinberg [5] proposed the
existence of a 6 bp AC-stem. However, a 6 bp AC-stem is not
essential, because the three active mutants Y20 Y23 and Y24
[13] have G26 and A44, which cannot base-pair. The active
X3 mutant described in the next section has also an unpaired
U26 and C44. They only have a 5 bp AC-stem, showing that a
6 bp AC-stem is not essential for serylation and selenylation.
3.3. The orientation of the V-arm in£uences the selenylation
activity, not serylation
Fig. 3 (upper panel) shows the structure of the V-arms of a
few tRNASec mutants. These mutants di¡er at positions 44-45
and 48, at the junction of the V-arm. Therefore, the orienta-
tion of the V-arm is di¡erent and proposed tertiary structure
models for these mutants are shown in Fig. 3 (lower panel),
derived from [2]. According to the number at position 48, the
decrease of the position 44-45, the V-arm bends to the AC-
arm and leaves from the T-loop. The selenylation activity, as
shown in the parentheses of Fig. 3, decreased according to the
bend of the V-arm. Mutants X2 and X3 were active, while
mutant X4 was inactive. As a matter of fact, the native
tRNASec mutants X2, X3 and X4 all displayed full serylation
activity (data not shown). These results suggest that SecS
directly or indirectly recognizes the orientation of the V-arm
as well as the other two key elements, the 9 bp AA-stem and
the 6 bp D-stem. SecS may bind inside the L-shape tRNA and
may cover the V-arm. However, it is possible that the orien-
tation of the V-arm indirectly in£uences the active tRNA
structure for recognition by SecS and there may be some
base-speci¢city for recognition of the V-arm by SerRS and
SecS.
We suppose that Steinberg and coworkers insisted on the 7/
5-bulge model in order to deduce a general 7/5 secondary
structure for all tRNAs. However, the 5 bp T-stem+one bulge
is not identical to the 5 bp-only in a tRNA structure. And
their model of 7/5 secondary structure contains the four bases
between AA-stem and D-stem, inconsistent with two bases of
almost all tRNAs. Steinberg stands that all tRNAs must ¢t
the L-type secondary structure model. Surprisingly, even mi-
tochondrial tRNAs missing the D or T-arms ¢t the L-type [6].
However, one should take into account that biological sys-
tems can contain exceptions, such as the tRNASec with the
9/4 secondary structure. The 9/4 structure of the tRNASec is a
true fact among Archaea and Eukarya. Mutant X33 having
the 9/5 structure is well selenylated but scarcely serylated [14].
This means that SecS did not recognize the length of the T-
stem but that SerRS measures the length of domain II. The
tRNA mutants having 12 or 13 bp of domain II were accept-
able by SerRS but mutants having 11 or 14 bp of domain II
were not recognized by SerRS. Thus, SecS accepts mutants
having 12, 13, and 14 bp of domain II.
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Fig. 3. Relationships between the orientation of V-arm and the sele-
nylation activity. Upper panel: Secondary structure of the V-arm in
the wt tRNASec, mutants X2, X3 and X4. Lower panel: Proposed
tertiary structure models for these mutants; parentheses indicate the
relative selenylation activity (Vmax/Km of wt = 1).
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